India’s pharmaceutical exports grew a robust 10.72% in 2018-19, and raced past the $19-billion mark for the first time, a performance marked by a rebound in the U.S. market, improved show in almost all the top 25 destinations and across categories.
Exports touched $19.13 billion as against $17.28 billion of 2017-18, the previous highest, details available with Pharmaceuticals Export Promotion Council of India show. While it fell short of the $20-billion mark that was widely expected to be crossed, the performance was still special. Though pharma exports have done relatively better with the nearly 25% rise to $13.30 billion in 2011-12, the circumstances under which the latest performance came were different, Pharmexcil Director General Ravi Uday Bhaskar said.
SOURCE: The Hindu